Related Experiment Video
Updated: Aug 11, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6
Bingwei Dong1, Fenjuan Zhang1, Weibo Zhang1
1Department of Pathology, Xianyang Central Hospital, Xianyang City, 712000 Shaanxi Province, China.
Abstract:
Non-small-cell lung cancer (NSCLC) is the major subtype of lung cancer, with a series of long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and proteins involved in its pathogenesis. This study sought to investigate the functionality of lncRNA EPB41L4A antisense RNA 1 (lncRNA EPB41L4A-AS1) in the proliferation of NSCLC cells and provide a novel theoretical reference for NSCLC treatment. Levels of lncRNA EPB41L4A-AS1, miR-105-5p, and GTPase, IMAP family member 6 (GIMAP6) in tissues and cells were measured by RT-qPCR and the correlation between lncRNA EPB41L4A-AS1 and clinicopathological characteristics was analyzed. Cell proliferation was evaluated by cell counting kit-8 and colony formation assays. The subcellular localization of lncRNA EPB41L4A-AS1 was analyzed by the subcellular fractionation assay and the binding of miR-105-5p to lncRNA EPB41L4A-AS1 or GIMAP6 was analyzed by dual-luciferase and RNA pull-down assays. Functional rescue experiments were performed to analyze the role of miR-105-5p/GIMAP6 in NSCLC cell proliferation. lncRNA EPB41L4A-AS1 and GIMAP6 were downregulated while miR-105-5p was upregulated in NSCLC tissues and cells. lncRNA EPB41L4A-AS1 was correlated with tumor size and clinical staging and its overexpression reduced NSCLC cell proliferation. lncRNA EPB41L4A-AS1 was negatively correlated with miR-105-5p and positively correlated with GIMAP6 in NSCLC tissues, and lncRNA EPB41L4A-AS1 sponged miR-105-5p to promote GIMAP6 transcription in NSCLC cells. Overexpression of miR-105-5p or knockdown of GIMAP6 reversed the inhibition of lncRNA EPB41L4A-AS1 overexpression on NSCLC cell proliferation. lncRNA EPB41L4A-AS1 was downregulated in NSCLC and mitigated NSCLC cell proliferation through the miR-105-5p/GI-MAP6 axis.
Insights
Long non-coding RNA EPB41L4A-AS1 (lncRNA EPB41L4A-AS1) is downregulated in non-small-cell lung cancer (NSCLC). Overexpression of lncRNA EPB41L4A-AS1 inhibits NSCLC cell proliferation by regulating the miR-105-5p/GIMAP6 axis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small-cell lung cancer (NSCLC) is the predominant form of lung cancer.
- Long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and proteins play critical roles in NSCLC pathogenesis.
- Understanding the specific roles of these molecules is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the function of lncRNA EPB41L4A-AS1 in NSCLC cell proliferation.
- To elucidate the molecular mechanism involving lncRNA EPB41L4A-AS1, miR-105-5p, and GIMAP6 in NSCLC.
- To provide a theoretical basis for NSCLC treatment.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) to measure lncRNA EPB41L4A-AS1, miR-105-5p, and GIMAP6 levels.
- Cell counting kit-8 and colony formation assays to assess cell proliferation.
- Dual-luciferase reporter and RNA pull-down assays to determine molecular interactions.
- Subcellular fractionation and functional rescue experiments.
Main Results:
- lncRNA EPB41L4A-AS1 and GIMAP6 were downregulated, while miR-105-5p was upregulated in NSCLC tissues and cells.
- lncRNA EPB41L4A-AS1 expression correlated with tumor size and clinical stage.
- lncRNA EPB41L4A-AS1 suppressed NSCLC cell proliferation by sponging miR-105-5p, thereby promoting GIMAP6 transcription.
Conclusions:
- lncRNA EPB41L4A-AS1 acts as a tumor suppressor in NSCLC.
- The lncRNA EPB41L4A-AS1/miR-105-5p/GIMAP6 axis is a key regulatory pathway in NSCLC proliferation.
- Targeting this axis may offer a novel therapeutic approach for NSCLC.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

